Localized lipoatrophy after glatiramer acetate injection in patients with remitting-relapsing multiple sclerosis.
Drago
F
F
Brusati
C
C
Mancardi
G
G
Murialdo
A
A
Rebora
A
A
D000328:Adult; D005260:Female; D000068717:Glatiramer Acetate; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008060:Lipodystrophy / Q000139:chemically induced*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010455:Peptides / Q000009:adverse effects*; D012008:Recurrence
D007166:Immunosuppressive Agents; D010455:Peptides; D000068717:Glatiramer Acetate